DK705488D0 - Farmaceutisk praeparat - Google Patents

Farmaceutisk praeparat

Info

Publication number
DK705488D0
DK705488D0 DK705488A DK705488A DK705488D0 DK 705488 D0 DK705488 D0 DK 705488D0 DK 705488 A DK705488 A DK 705488A DK 705488 A DK705488 A DK 705488A DK 705488 D0 DK705488 D0 DK 705488D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
DK705488A
Other languages
English (en)
Other versions
DK175220B1 (da
DK705488A (da
Inventor
Danielle Giron
Freidrich Richter
Martin List
Yasuyuki Uike
Hans Peter Weber
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK705488D0 publication Critical patent/DK705488D0/da
Publication of DK705488A publication Critical patent/DK705488A/da
Application granted granted Critical
Publication of DK175220B1 publication Critical patent/DK175220B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK198807054A 1987-12-21 1988-12-19 Ciclosporin, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt dets anvendelse DK175220B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US13623087 1987-12-21
US17261388A 1988-03-24 1988-03-24
US17261388 1988-03-24
US21254888A 1988-06-28 1988-06-28
US21254888 1988-06-28

Publications (3)

Publication Number Publication Date
DK705488D0 true DK705488D0 (da) 1988-12-19
DK705488A DK705488A (da) 1989-06-22
DK175220B1 DK175220B1 (da) 2004-07-12

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198807054A DK175220B1 (da) 1987-12-21 1988-12-19 Ciclosporin, fremgangsmåde til fremstilling deraf, farmaceutisk præparat med indhold deraf samt dets anvendelse

Country Status (27)

Country Link
JP (1) JPH0791316B2 (da)
KR (1) KR100188305B1 (da)
AT (1) AT403163B (da)
AU (1) AU626274B2 (da)
BE (1) BE1002665A4 (da)
CA (1) CA1341396C (da)
CH (1) CH677926A5 (da)
CY (1) CY1799A (da)
DE (1) DE3843054C2 (da)
DK (1) DK175220B1 (da)
ES (1) ES2012580A6 (da)
FI (1) FI89065C (da)
FR (1) FR2624863B1 (da)
GB (1) GB2211848B (da)
GR (1) GR1002486B (da)
HK (1) HK102894A (da)
HU (1) HU203564B (da)
IE (1) IE62006B1 (da)
IL (1) IL88719A0 (da)
IT (1) IT1235356B (da)
LU (1) LU87409A1 (da)
MY (1) MY103943A (da)
NL (1) NL195096C (da)
NO (1) NO177228C (da)
NZ (1) NZ227384A (da)
SE (1) SE503174C2 (da)
SG (1) SG99494G (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
HK1004520A1 (en) * 1992-05-13 1998-11-27 Novartis Ag Ophthalmic compositions containing a cyclosporin
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) * 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
SK285019B6 (sk) 1997-01-30 2006-04-06 Novartis Ag Tvrdá želatínová tobolka
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE602005011928D1 (de) 2004-01-20 2009-02-05 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
MY180581A (en) * 2011-05-27 2020-12-02 Allergan Inc A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
BR112014011768A2 (pt) * 2011-11-15 2017-05-09 Allergan Inc forma 2 de ciclosporina a e método de produção da mesma
WO2013074610A1 (en) 2011-11-15 2013-05-23 Allergan, Inc. Sustained action formulation of cyclosporin form 2
EP3701939A1 (en) * 2011-11-15 2020-09-02 Allergan, Inc. Suspensions of cyclosporin a form 2
US20130123194A1 (en) * 2011-11-15 2013-05-16 Allergan, Inc. Autoclavable suspensions of cyclosporin a form 2
TW202430537A (zh) * 2022-10-20 2024-08-01 日商中外製藥股份有限公司 環狀胜肽的結晶的製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (da) * 1975-11-04 1979-12-28 Sandoz Ag
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
DE3843054C2 (de) 2003-08-21
GR880100850A (el) 1994-03-31
FR2624863B1 (fr) 1991-04-26
JPH01211598A (ja) 1989-08-24
BE1002665A4 (fr) 1991-04-30
ATA309588A (de) 1997-04-15
NL195096C (nl) 2004-02-09
NO885625L (no) 1989-06-22
NL8803125A (nl) 1989-07-17
CY1799A (en) 1995-02-17
GB2211848A (en) 1989-07-12
HUT49893A (en) 1989-11-28
DE3843054A1 (de) 1989-07-27
IT1235356B (it) 1992-06-30
HK102894A (en) 1994-09-30
AT403163B (de) 1997-11-25
CH677926A5 (da) 1991-07-15
SE503174C2 (sv) 1996-04-15
AU626274B2 (en) 1992-07-30
SE8804570D0 (sv) 1988-12-19
FI89065C (fi) 1993-09-30
IE883779L (en) 1989-06-21
NO177228B (no) 1995-05-02
SG99494G (en) 1994-10-28
ES2012580A6 (es) 1990-04-01
DK175220B1 (da) 2004-07-12
GR1002486B (el) 1996-12-09
HU203564B (en) 1991-08-28
DK705488A (da) 1989-06-22
IE62006B1 (en) 1994-12-14
FI885869L (fi) 1989-06-22
FI89065B (fi) 1993-04-30
SE8804570L (sv) 1989-06-22
MY103943A (en) 1993-10-30
IL88719A0 (en) 1989-07-31
KR100188305B1 (ko) 1999-06-01
FR2624863A1 (fr) 1989-06-23
FI885869A0 (fi) 1988-12-19
KR890009975A (ko) 1989-08-05
GB8829556D0 (en) 1989-02-08
JPH0791316B2 (ja) 1995-10-04
IT8848690A0 (it) 1988-12-20
NO885625D0 (no) 1988-12-19
NO177228C (no) 1995-08-09
GB2211848B (en) 1991-11-06
LU87409A1 (fr) 1989-07-07
CA1341396C (en) 2002-11-05
NZ227384A (en) 1991-09-25
AU2705588A (en) 1989-06-22

Similar Documents

Publication Publication Date Title
DK89090A (da) Farmaceutisk praeparat
SE8801813D0 (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
DK195988D0 (da) Farmaceutisk praeparat indeholdende mikrokapsler
DK546886D0 (da) Farmaceutisk praeparat
DK686187D0 (da) Veterinaert praeparat
DK100488D0 (da) Farmaceutisk plaster
DK489189A (da) Farmaceutisk praeparat
IS3339A7 (is) Ný efnablanda lyfja
DK705488A (da) Farmaceutisk praeparat
DK435688A (da) Farmaceutiske midler
DK603988D0 (da) Farmaceutisk praeparat
DK336489A (da) Farmaceutisk praeparat
DK139388D0 (da) Farmaceutisk praeparat
DK276288D0 (da) Farmaceutisk praeparat
BR9006025A (pt) Preparacao farmaceutica
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK138888A (da) Farmaceutisk praeparat
DK662587D0 (da) Herbicidt praeparat
DK638889A (da) Farmaceutisk kombinationspraeparat
DK428287A (da) Nasalt farmaceutisk praeparat
SE8602975D0 (sv) Farmaceutisk beredning
SE8603912D0 (sv) Farmaceutisk beredning
FI910224A7 (fi) Farmaseuttinen valmiste
DK408189D0 (da) Farmaceutisk praeparat

Legal Events

Date Code Title Description
PUP Patent expired